ML40787, entitled, A Phase III, prospective, double-blind, randomized, placebo-controlled trial ofTENECTEPLASE IN IMAGING-ELIGIBLE, LATE-WINDOW PATIENTS TO ASSESS THE EFFICACY ANDSAFETY OF TENECTEPLASE (TIMELESS)

Project: Research project

Description

ML40787, entitled, A Phase III, prospective, double-blind, randomized, placebo-controlled trial of TENECTEPLASE IN IMAGING-ELIGIBLE, LATE-WINDOW PATIENTS TO ASSESS THE EFFICACY AND SAFETY OF TENECTEPLASE (TIMELESS)
StatusActive
Effective start/end date1/1/1912/31/24

Funding

  • Genentech Inc.

Fingerprint

Randomized Controlled Trials
Placebos
Safety
tenecteplase